Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Details of Primary Research
1.5.1. Data for Primary Interviews in the U.S.
1.5.2. Data for Primary Interviews in Canada
1.6. Information or Data Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity flow analysis (Model 1)
1.8.2. Approach 1: Commodity flow approach
1.8.3. Parent Market Analysis (Model 2)
1.8.4. Approach 2: Parent Market Analysis
1.9. List of Secondary Sources
1.10. List of Primary Sources
1.11. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. North America Topical Drugs CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological advancements & growing R&D investments
3.2.1.2. Rising demand for topical medications
3.2.1.3. Expansion of manufacturing capacities and partnerships
3.2.2. Market Restraint Analysis
3.2.2.1. Compliance with strict regulatory requirements
3.2.2.2. Limited efficacy in certain conditions limits adoption of topical products
3.3. North America Topical Drugs CDMO Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.4. Pricing Analysis
3.5. Topical Drugs CDMO Capacity Outlook
3.5.1. CDMO Manufacturing Container Capacity
3.5.2. Topical Drugs Container Capacity By Product Type
3.6. North America Topical Drugs CDMO Market Outlook By Product Category
3.6.1. North America Topical Drugs CDMO Market Share, by Product Category, 2023 (%)
3.6.2. Prescription Drugs
3.6.2.1. Segment Overview
3.6.2.2. Major Prescription Drugs, by Product Type
3.6.3. Generic Drugs
3.6.3.1. Segment Overview
3.6.3.2. Major Generic Drugs, by Product Type
3.6.4. Over-the-counter (OTC) Drugs
3.6.4.1. Segment Overview
3.6.4.2. Major OTC Drugs, by Product Type
3.7. Impact of COVID-19 Pandemic
Chapter 4. North America Topical Drugs CDMO Market: Product Type Estimates & Trend Analysis
4.1. Product Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. North America Topical Drugs CDMO Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Semi-solid Formulations
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Creams
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Ointments
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Lotions
4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.5. Others
4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Liquid Formulations
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Suspensions
4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Solutions
4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Solid Formulations
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Transdermal Products
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. North America Topical Drugs CDMO Market: Service Type Estimates & Trend Analysis
5.1. Service Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. North America Topical Drugs CDMO Market by Service Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Contract Development
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2. Formulation Development
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3. Analytical Testing
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.4. Stability Testing
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.5. Others
5.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Contract Manufacturing
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Clinical
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.3. Commercial
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. North America Topical Drugs CDMO Market: Sponsors Estimates & Trend Analysis
6.1. Sponsors Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. North America Topical Drugs CDMO Market by Sponsors Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Pharmaceutical Companies
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Biopharmaceutical Companies
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. North America Topical Drugs CDMO Market: Country Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2023 & 2030
7.2. Country Market Dashboard
7.3. Country Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. U.S.
7.5.1. Key country dynamics
7.5.2. Regulatory framework
7.5.3. Competitive scenario
7.5.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Canada
7.6.1. Key country dynamics
7.6.2. Regulatory framework
7.6.3. Competitive scenario
7.6.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.1.1. Innovators
8.1.2. Market Leaders
8.1.3. Emerging Players
8.1.4. Company Market Share Analysis, 2023
8.2. Company Profiles
8.2.1. The Lubrizol Corporation
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product/service benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Cambrex Corporation
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product/service benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Contract Pharmaceuticals Limited
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product/service benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Bora Pharmaceutical CDMO
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product/service benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Ascendia Pharmaceuticals
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product/service benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Pierre Fabre S.A.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product/service benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Piramal Pharma Solutions
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product/service benchmarking
8.2.7.4. Strategic initiatives
8.2.8. DPT Laboratories, LTD.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product/service benchmarking
8.2.8.4. Strategic initiatives
8.2.9. MedPharm Ltd.
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product/service benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Zenvisionpharma
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product/service benchmarking
8.2.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Topical Drugs CDMO: Market Revenue Estimates and Forecast, 2018-2030 (USD Billion)
Table 4 Global Topical Drugs: Market Revenue Estimates and Forecast, 2018-2030 (USD Billion)
Table 5 Development Stages Baseline Model Parameter Estimates, By Topical Drugs
Table 6 Global Topical Drugs CDMO Manufacturing Container Capacity/Batch
Table 7 Global Topical Drugs Capacity, by Product Type (per unit)
Table 8 Global Topical Drugs Capacity, by Container Type (per unit)
Table 9 North America Topical Drugs CDMO Market Share, By Product Category, 2023 (%)
Table 10 List of Major Prescription Drugs, by Product Type (2022)
Table 11 List of Major Generic Drugs, by Product Type (2022)
Table 12 List of major OTC Drugs, by Product Type (2022)
Table 13 North America Topical Drugs CDMO market revenue estimates and forecast, by Product type, 2018-2030 (USD Million)
Table 14 North America Topical Drugs CDMO market revenue estimates and forecast, by Semi-solid formulations, 2018-2030 (USD Million)
Table 15 North America Topical Drugs CDMO market revenue estimates and forecast, by Liquid formulations drugs, 2018-2030 (USD Million)
Table 16 North America Topical Drugs CDMO market revenue estimates and forecast, by service type, 2018-2030 (USD Million)
Table 17 North America Topical Drugs CDMO market revenue estimates and forecast, by contract development, 2018-2030 (USD Million)
Table 18 North America Topical Drugs CDMO market revenue estimates and forecast, by contract manufacturing, 2018-2030 (USD Million)
Table 19 North America Topical Drugs CDMO market revenue estimates and forecast, by sponsors, 2018-2030 (USD Million)
Table 20 North America Topical Drugs CDMO market revenue estimates and forecast, by country, 2018-2030 (USD Million)
Table 21 Company profiles: Company overview
Table 22 Company profiles: Financial performance
Table 23 Company profiles: Service benchmarking
Table 24 Key Company initiating service launches/upgrades
Table 25 Key companies initiating mergers/acquisitions/joint ventures
Table 26 Key companies initiating partnerships
Table 27 Key companies initiating expansion
Table 28 Key companies initiating others
List of Figures
Fig. 1 North America topical drugs CDMO market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Global topical drugs CDMO market outlook, 2023 (USD Billion)
Fig. 13 Global topical drugs market outlook, 2023 (USD Billion)
Fig. 14 North America topical drugs CDMO market dynamics
Fig. 15 Porter’s Five Forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 North America Topical Drugs CDMO market: Product Type outlook and key takeaways
Fig. 18 North America Topical Drugs CDMO market: Product Type movement analysis
Fig. 19 Semi-solid formulations market estimates and forecast, 2018-2030 (USD Million)
Fig. 20 Creams market estimates and forecast, 2018-2030 (USD Million)
Fig. 21 Ointments market estimates and forecast, 2018-2030 (USD Million)
Fig. 22 Lotions market estimates and forecast, 2018-2030 (USD Million)
Fig. 23 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 24 Liquid formulations market estimates and forecast, 2018-2030 (USD Million)
Fig. 25 Suspensions market estimates and forecast, 2018-2030 (USD Million)
Fig. 26 Solutions market estimates and forecast, 2018-2030 (USD Million)
Fig. 27 Solid formulations market estimates and forecast, 2018-2030 (USD Million)
Fig. 28 Transdermal products market estimates and forecast, 2018-2030 (USD Million)
Fig. 29 North America Topical Drugs CDMO market: Service type outlook and key takeaways
Fig. 30 North America Topical Drugs CDMO market: Service type movement analysis
Fig. 31 Contract development market estimates and forecast, 2018-2030 (USD Million)
Fig. 32 Formulation development market estimates and forecast, 2018-2030 (USD Million)
Fig. 33 Analytical testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 34 Stability testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 35 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 36 Contract manufacturing market estimates and forecast, 2018-2030 (USD Million)
Fig. 37 Clinical market estimates and forecast, 2018-2030 (USD Million)
Fig. 38 Commercial market estimates and forecast, 2018-2030 (USD Million)
Fig. 39 North America Topical Drugs CDMO market: sponsors outlook and key takeaways
Fig. 40 North America Topical Drugs CDMO market: sponsors movement analysis
Fig. 41 Pharmaceutical companies market estimates and forecast, 2018-2030 (USD Million)
Fig. 42 Biopharmaceutical companies market estimates and forecast, 2018-2030 (USD Million)
Fig. 43 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 44 North America Topical Drugs CDMO market revenue, by country, 2023 & 2030 (USD Million)
Fig. 45 Regional outlook, 2023 & 2030
Fig. 46 Regional Market Share Analysis, 2023 & 2030
Fig. 47 North America Topical Drugs CDMO market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 U.S. Topical Drugs CDMO market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Canada Topical Drugs CDMO market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 Market participant categorization
Fig. 53 Market participant categorization
Fig. 54 Heat map analysis
